Are supplemental appraisal/reimbursement processes needed for rare disease treatments? An international comparison of country approaches

Overview of attention for article published in Orphanet Journal of Rare Diseases, July 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

So far, Altmetric has seen 4 news stories from 4 outlets.

Casi la mitad de los nuevos medicamentos huérfanos que se aprueban en Europa no llegan a España, y los que lo hacen tardan una…

Alrededor de 3 millones de españoles (30 millones de europeos) padecen algún tipo de enfermedad considerada poco frecuente…

Alrededor de tres millones de españoles padecen algún tipo de enfermedad considerada poco frecuente, esto es, patologías que…

A study looking at the ways in which different countries handle appraisal and reimbursement processes for rare disease…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.